Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC
Clinical trial NCT05765825 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05765825
- Sponsor
- Sichuan University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-07
- Primary completion
- 2024-07-31
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.